PPX delivers strategic advisory for internationalisation, regional expansion and emerging markets — regulatory compliance paired with a curated global network across genetics, production and joint ventures, so new markets open faster.
Powered by Prohibition Partners: the market intelligence, institutional networks and category leadership behind the global industry.
Our work features in
PPX is a strategic pillar within Prohibition Partners — the organisation that has tracked, analysed and shaped the global cannabis industry for a decade.
Our clients don't just get campaigns. They get proprietary market intelligence, direct introductions to investors and operators, visibility through the world's largest B2B cannabis media network, and strategic guidance informed by regulatory insight across every major market.
We turn that platform into commercial outcomes: faster launches, smarter positioning, stronger networks, measurable growth.
- 150K+social media followers
- 110K+email subscribers
- 50M+mainstream media reach
- 1.2M+annual pageviews
Roots to Growth
Growth through media & advisory
Growth in regulated markets demands strategy, not shortcuts. Each service names its mechanism and is built to deliver measurable, compliant commercial outcomes.
All servicesEntering or scaling a regulated market takes dedicated, tenured expertise.
Feasible, validated market-entry options — informed by Prohibition Partners' proprietary data, regulatory review before anything ships, and introductions that compress a market entry from months to weeks. We advise on positioning, licensing pathways and route to market, then stay accountable for what happens next.
A network you can't reach is a network you don't have.
Lead generation, sales pipeline and partner development built on the group's operator, investor and clinical relationships — with business plans your BD team and executives can run. We open the rooms — Cannabis Europa, the media brands, a decade of direct relationships — and build the follow-through that turns them into revenue.
A brand that reads as credible to regulators, investors and buyers at once.
Positioning, identity and design systems for companies that have outgrown their founding story. Category-defining work for medical cannabis leaders and growth-stage operators — built to pass diligence, not just look good in a deck.
The coverage that matters comes from the journalists covering the sector seriously.
Media strategy, thought leadership, investor relations and corporate messaging — backed by direct access to Prohibition Partners' global media network. The Prohibition Partners team works as an extension of your own, putting brands in front of a global ecosystem of cannabis business professionals, within the rules.
Compliant campaigns that generate demand, not just impressions.
Campaign strategy, content and demand generation for regulated categories, with messaging reviewed against current regulation before it goes live. Companies that communicate effectively within the rules have an edge over those that can't.
The industry meets in rooms we build.
Sponsorship strategy, curated activations and bespoke events run by the team behind Cannabis Europa — designed around the outcome, not the theatre. We get the right people in the room, then make the room work: presence into pipeline.
“PPX have been an extremely influential partner in getting our message and identity out to the UK medical cannabis market. Their team always goes above and beyond.”
Proven Impact
Judged on outcomes
We've built category-defining brands and executed market-shaping campaigns for medical cannabis leaders, institutional operators and growth-stage companies across Europe and beyond.
An identity that makes revolutionary treatment feel safe — a genuine nest for people seeking unconventional care.
8.1 million impressions and engagement above category benchmarks — a year of leading the UK medical cannabis conversation.
A global risk briefing read 12,000 times across 46 countries — 340+ leads, half of them C-suite or founders.
An identity where the THC:CBD ratio is the visual centrepiece — clinical-grade trust, built to scale into international markets.